Andrew Perry
Corporate Officer/Principal bij G1 THERAPEUTICS, INC.
Vermogen: 304 751 $ op 30-04-2024
Profiel
Andrew Perry is currently the Chief Commercial Officer at G1 Therapeutics, Inc. He previously worked as the Vice President of US Marketing at ViiV Healthcare Ltd.
Mr. Perry is a graduate of the University of Glasgow and The University of Sheffield.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
G1 THERAPEUTICS, INC.
0.15% | 13-05-2024 | 78 951 ( 0.15% ) | 304 751 $ | 30-04-2024 |
Actieve functies van Andrew Perry
Bedrijven | Functie | Begin |
---|---|---|
G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 02-08-2021 |
Eerdere bekende functies van Andrew Perry
Bedrijven | Functie | Einde |
---|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Andrew Perry
University of Glasgow | Graduate Degree |
The University of Sheffield | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
G1 THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |